A New Downstream Process for Large Scale Manufacturing of AAV9 Vectors

被引：0
|
作者：
Hebben, Matthias [1 ]
机构：
[1] Genethon, Evry, France
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
INV078
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [1] Transient transfection at large scale for clinical AAV9 vector manufacturing
    Legmann, R.
    [J]. CYTOTHERAPY, 2020, 22 (05) : S151 - S151
  • [2] Characterization of HSV Derived AAV9 Vectors
    Pechan, Peter
    Golebiowski, Diane
    Seregin, Alexey
    Zapata, Nicole
    Levi, Elise
    Kitsos, Christine
    Lu, Robert
    Amorrortu, Alvaro
    Morris, Carl
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 347 - 347
  • [3] Improved AAV1 and AAV9 Vectors for Gene Delivery
    Balakrishnan, Balaji
    Krishnagopal, Akshaya
    Sen, Dwaipayan
    Srivastava, Alok
    Jayandharan, Giridhara R.
    [J]. MOLECULAR THERAPY, 2013, 21 : S130 - S131
  • [4] Intrathecal delivery of AAV9 vectors to model and rescue a large animal model of SMA
    Duque, S.
    Porensky, P.
    William, D. A.
    Odermatt, P.
    Nlend, R. Nlend
    Bevan, A. K.
    Foust, K.
    Braun, L.
    Schmelzer, L.
    Schumperli, D.
    Kaspar, B. K.
    Burghes, A. H. M.
    [J]. NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 797 - 797
  • [5] Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
    Skorput, Alexander G. J.
    Gore, Reshma
    Schorn, Rachel
    Riedl, Maureen S.
    de Velasco, Ezequiel Marron Fernandez
    Hadlich, Bailey
    Kitto, Kelley F.
    Fairbanks, Carolyn A.
    Vulchanova, Lucy
    [J]. PLOS ONE, 2022, 17 (03):
  • [6] Optimization of elution conditions for immunoaffinity chromatography of AAV5 and AAV9 vectors
    Iurlova, E. V.
    Rebelin, M. S.
    Stukanev, V. K.
    Perepelkina, M. P.
    Gershovich, P. M.
    Madera, D. A.
    Karabelskii, A. V.
    Ivanov, R. A.
    Prokofyev, A. V.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A24 - A25
  • [7] AAV large scale manufacturing
    Neri, M.
    Rossetti, F.
    Ungari, S.
    Simonetti, E.
    Bonfanti, F.
    Testasecca, A.
    Lorenzetti, F.
    Meraviglia, V.
    Vallanti, G.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A109 - A109
  • [8] Demonstration of Transient Transfection Scalability for a Suspension AAV9 Viral Vector Production Process up to 500 Liter Manufacturing Scale
    MacIntyre, Anne
    Erlandson, Tim
    Kang, Benedict
    Hazi, Nathan
    Sanderson, Todd
    Ingersoll, Benjamin I.
    McLaughlin, Michael
    Maples, Phillip B.
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 390 - 390
  • [9] Widespread vector distribution following intra-CSF delivery of AAV9 vectors in a large animal model
    Haurigot, Virginia
    Marco, Sara
    Ribera, Albert
    Garcia, Miquel
    Ruzo, Albert
    Villacampa, Pilar
    Ayuso, Eduard
    Anor, Sonia
    Andaluz, Anna
    Pineda, Mercedes
    Garcia Fructoso, Gemma
    Molas, Maria
    Maggioni, Luca
    Motas, Sandra
    Ruberte, Jesus
    Mingozzi, Federico
    Pumarola, Marti
    Bosch, Fatima
    [J]. HUMAN GENE THERAPY, 2012, 23 (10) : A47 - A47
  • [10] Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors
    Hollidge, Bradley S.
    Carroll, Hayley B.
    Qian, Randolph
    Fuller, Madison L.
    Giles, April R.
    Mercer, Andrew C.
    Danos, Olivier
    Liu, Ye
    Bruder, Joseph T.
    Smith, Jared B.
    [J]. FRONTIERS IN NEUROLOGY, 2022, 13
12345